NEOLA — Neola Medical AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK143.11m
- SEK121.53m
- 23
- 23
- 64
- 27
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 5.36 | 16.6 | 22.9 | 40.1 | 21.6 |
Net Total Receivables | 0.355 | 0.563 | 1.45 | 1.02 | 20.9 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 5.85 | 17.4 | 24.8 | 41.6 | 43.1 |
Net Property, Plant And Equipment | 0.013 | 0.007 | 0.162 | 0.223 | 0.137 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 12.2 | 26 | 43.8 | 75.3 | 86 |
Accounts Payable | |||||
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.5 | 2.42 | 3.19 | 5.34 | 6.16 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.5 | 2.42 | 3.19 | 7.84 | 6.99 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 10.7 | 23.5 | 40.6 | 67.5 | 79 |
Total Liabilities & Shareholders' Equity | 12.2 | 26 | 43.8 | 75.3 | 86 |
Total Common Shares Outstanding |